Related Experiment Video

Updated: Sep 29, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Recognition and treatment of endocrine/metabolic emergencies in children: part I

Michael S Kappy1, Lalit Bajaj

  • 1University of Colorado Health Sciences Center, The Children's Hospital, Denver, USA.

Advances in Pediatrics
|September 7, 2002
PubMed

Insights

Pediatric endocrine and metabolic emergencies present with varied symptoms, often delaying diagnosis. Prompt laboratory evaluation before treatment is crucial for accurate diagnosis and preventing severe outcomes like coma or death.

Area of Science:

  • Pediatric Emergency Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Endocrine/metabolic emergencies in children can be isolated, initial manifestations, or acute issues in known conditions.
  • Signs and symptoms are often nonspecific, posing diagnostic challenges for pediatric emergency providers.
  • Delayed or missed diagnoses can lead to severe consequences, including cerebral dysfunction, coma, or death.

Purpose of the Study:

  • To highlight the challenges in diagnosing pediatric endocrine/metabolic emergencies.
  • To emphasize the importance of prompt laboratory specimen collection for accurate diagnosis.

Main Methods:

  • Review of common endocrine/metabolic emergencies in pediatric populations.
  • Discussion of diagnostic pitfalls and consequences of delayed diagnosis.

Main Results:

  • Nonspecific signs and symptoms frequently complicate the diagnosis of pediatric endocrine/metabolic disorders.
  • Critical laboratory specimens are essential for timely and accurate diagnosis.

Conclusions:

  • Prompt diagnosis of pediatric endocrine/metabolic emergencies is vital.
  • Collection of critical laboratory specimens before nonspecific therapy is paramount for preventing severe patient outcomes.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...